Sweden· SE-19930618000049
Granocyte 34 miljoner IE/ml Pulver och vätska till injektions-/infusionsvätska, lösning
A medicinal product containing lenograstim, registered in Sweden by Sanofi AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Lenograstim
- Manufacturer
- Sanofi AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer19930618000049
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lenograstim in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceGRANOCYTE 13 Millions UI/ml, poudre et solvant pour solution injectable/perfusion en seringue préremplieCHUGAI PHARMA FRANCE
- United KingdomGranocyte 13million unit powder and solvent for solution for injection pre-filled syringesChugai Pharma UK Ltd
- FinlandGranocyteSanofi Oy
- Japanレノグラスチム（遺伝子組換え）中外製薬
- BelgiumGranocyte 13 1 10*6 IU/mlChugai Pharma France
- GermanyGranocyteChugai Pharma Germany Gmbh
- SpainGRANOCYTE 13 MILLONES DE UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE O PERFUSIONItalfarmaco S.A.
- IrelandGRANOCYTE 13 million IU/mL, powder and solvent for solution for injection/infusion, in a pre-filled syringeChugai Pharma France
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Belgium · Granocyte
- Germany · Granocyte
- France · Granocyte
- United Kingdom (Northern Ireland) · Granocyte
- Ireland · Granocyte
- Luxembourg · Granocyte
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/91c6d165-fb8a-481b-aff8-c2c7bb36efd6 GET /v1/drugs/91c6d165-fb8a-481b-aff8-c2c7bb36efd6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "19930618000049",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19930618000049",
"product_doc_link": "https://docetp.mpa.se/LMF/Granocyte%20powder%20and%20solvent%20for%20solution%20for%20injection%20and%20infusion%20SmPC_09001bee807a4061.pdf"
}See everything about lenograstim.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.